Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamal Desai

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Vaccine|February 21, 2012
Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccineKamal Desai, L Coudeville, F Bailleux
Multiple Sclerosis and Related Disorders|June 17, 2020
Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysisKevin Yan, Chakrapani Balijepalli, Kamal Desai, et al.
Emerging Themes in Epidemiology|October 13, 2009
Efficacy dilution in randomized placebo-controlled vaginal microbicide trialsBenoît R Mâsse, Marie-Claude Boily, Dobromir Dimitrov, et al.
Clinical Epidemiology|March 27, 2020
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature ReviewKevin Yan, Kamal Desai, Lakshmi Gullapalli, et al.
Sexually Transmitted Diseases|January 27, 2004
Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical modelsMarie-Claude Boily, Francisco I Bastos, Kamal Desai, et al.
BMC Medical Research Methodology|March 2, 2013
A threshold method for immunological correlates of protectionXuan Chen, Fabrice Bailleux, Kamal Desai, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 23, 2015
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysisSeye Abogunrin, Sarah Brand, Kamal Desai, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 2, 2017
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United KingdomMadhusubramanian Muthukumar, Kamal Desai, Seye Abogunrin, et al.
Pharmacoeconomics|June 8, 2014
Model-based cost-effectiveness analyses for the treatment of chronic myeloid leukaemia: a review and summary of challengesKevin Marsh, Peng Xu, Panagiotis Orfanos, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 14, 2020
Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug ReviewChakrapani Balijepalli, Lakshmi Gullapalli, Eric Druyts, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Vaccine|February 21, 2012
Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccineKamal Desai, L Coudeville, F Bailleux
Multiple Sclerosis and Related Disorders|June 17, 2020
Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysisKevin Yan, Chakrapani Balijepalli, Kamal Desai, et al.
Emerging Themes in Epidemiology|October 13, 2009
Efficacy dilution in randomized placebo-controlled vaginal microbicide trialsBenoît R Mâsse, Marie-Claude Boily, Dobromir Dimitrov, et al.
Clinical Epidemiology|March 27, 2020
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature ReviewKevin Yan, Kamal Desai, Lakshmi Gullapalli, et al.
Sexually Transmitted Diseases|January 27, 2004
Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical modelsMarie-Claude Boily, Francisco I Bastos, Kamal Desai, et al.
BMC Medical Research Methodology|March 2, 2013
A threshold method for immunological correlates of protectionXuan Chen, Fabrice Bailleux, Kamal Desai, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 23, 2015
AbobotulinumtoxinA in the management of cervical dystonia in the United Kingdom: a budget impact analysisSeye Abogunrin, Sarah Brand, Kamal Desai, et al.
Clinicoeconomics and Outcomes Research : CEOR|May 2, 2017
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United KingdomMadhusubramanian Muthukumar, Kamal Desai, Seye Abogunrin, et al.
Pharmacoeconomics|June 8, 2014
Model-based cost-effectiveness analyses for the treatment of chronic myeloid leukaemia: a review and summary of challengesKevin Marsh, Peng Xu, Panagiotis Orfanos, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 14, 2020
Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug ReviewChakrapani Balijepalli, Lakshmi Gullapalli, Eric Druyts, et al.
Pageof 2